1st International consensus guidelines for advanced breast cancer (ABC 1) Journal Article
| Authors: | Cardoso, F.; Costa, A.; Norton, L.; Cameron, D.; Cufer, T.; Fallowfield, L.; Francis, P.; Gligorov, J.; Kyriakides, S.; Lin, N.; Pagani, O.; Senkus, E.; Thomssen, C.; Aapro, M.; Bergh, J.; Di Leo, A.; El Saghir, N.; Ganz, P. A.; Gelmon, K.; Goldhirsch, A.; Harbeck, N.; Houssami, N.; Hudis, C.; Kaufman, B.; Leadbeater, M.; Mayer, M.; Rodger, A.; Rugo, H.; Sacchini, V.; Sledge, G.; van't Veer, L.; Viale, G.; Krop, I.; Winer, E. |
| Article Title: | 1st International consensus guidelines for advanced breast cancer (ABC 1) |
| Abstract: | The 1st international Consensus Conference for Advanced Breast Cancer (ABC 1) took place on November 2011, in Lisbon. Consensus guidelines for the management of this disease were developed. This manuscript summarizes these international consensus guidelines. © 2012 Elsevier Ltd. |
| Keywords: | overall survival; bevacizumab; cytotoxic agent; drug efficacy; multimodality cancer therapy; risk benefit analysis; antineoplastic agents; drug approval; bone metastasis; capecitabine; brain radiation; cancer staging; outcome assessment; positron emission tomography; neurosurgery; neoplasm staging; evidence based medicine; cancer palliative therapy; medical decision making; consensus; progression free survival; quality of life; breast cancer; antineoplastic combined chemotherapy protocols; epidermal growth factor receptor 2; aromatase inhibitor; bisphosphonic acid derivative; practice guideline; breast neoplasms; adaptation, psychological; laboratory test; radiosurgery; practice guidelines as topic; brain metastasis; tamoxifen; consensus development; physical examination; gonadorelin agonist; taxane derivative; trastuzumab; navelbine; anthracycline; metastatic breast cancer; guidelines; everolimus; lapatinib; fulvestrant; megestrol acetate; pertuzumab; male breast; international cooperation; orthopedic surgery; women's health; randomized controlled trial (topic); medical history; meta analysis (topic); denosumab; trastuzumab emtansine; drug preference; advanced breast cancer; abc 1; portugal |
| Journal Title: | Breast |
| Volume: | 21 |
| Issue: | 3 |
| ISSN: | 0960-9776 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2012-06-01 |
| Start Page: | 242 |
| End Page: | 252 |
| Language: | English |
| DOI: | 10.1016/j.breast.2012.03.003 |
| PROVIDER: | scopus |
| PUBMED: | 22425534 |
| DOI/URL: | |
| Notes: | --- - "Cited By (since 1996): 1" - "Export Date: 2 July 2012" - "CODEN: BREAE" - "Source: Scopus" |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work